Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 61 to 75 of 169 results for asthma

  1. News, blogs and podcasts

    Latest podcasts The asthma guideline – one year on In this episode of NICE Talks, we learn the impact of the joint asthma...

  2. Additional maintenance therapy for asthma uncontrolled on a moderate dose of ICS plus LABA with or without LTRA:- What is the clinical and cost effectiveness of offering additional maintenance therapy to adults, young people and children with asthma that is uncontrolled on a moderate dose of ICS plus LABA with or without LTRA?

    Recommendation ID NG80/8 Question Additional maintenance therapy for asthma uncontrolled on a moderate dose of ICS plus LABA with or...

    Research recommendation
    Published
    18 October 2018

  3. Increasing the dose of ICS within a personalised self-management programme for children and young people - For children and young people with asthma that is managed in primary care, is there an advantage to increasing the inhaled corticosteroid (ICS) dose when asthma control has deteriorated compared with using the usual dose in a self-management programme?

    people with asthma that is managed in primary care, is there an advantage to increasing the inhaled corticosteroid (ICS) dose when...

    Research recommendation
    Published
    6 August 2021

  4. Starting asthma treatment:- In adults, young people and children with asthma who have not been treated previously, is it more clinically and cost effective to start treatment with a reliever alone (a short-acting beta2 agonist [SABA]) or with a reliever (a SABA) and maintenance therapy (such as ICS)? Are there specificprognostic features that indicate that one of these treatment options may be more appropriate for some groups?

    ID NG80/6 Question Starting asthma treatment:- In adults, young people and children with asthma who have not been treated...

    Research recommendation
    Published
    18 October 2018

  5. Monitoring adherence to treatment:- What is the clinical and cost effectiveness of using electronic alert systems designed to monitor and improve adherence with regular inhaled maintenance therapy in people with asthma?

    and improve adherence with regular inhaled maintenance therapy in people with asthma? Any explanatory notes(if applicable) Why this is...

    Research recommendation
    Published
    18 October 2018

  6. Monitoring asthma control using tele-healthcare:- What is the long-term (more than 12 months) clinical and cost effectiveness of using telehealthcare as a means to monitor asthma control in adults, young people and children? Methods of tele-healthcare can include telephone interview (with healthcare professional involvement) andinternet or smartphone-based monitoring support (no healthcare professional involvement).

    Recommendation ID NG80/5 Question Monitoring asthma control using tele-healthcare:- What is the long-term (more than 12 months) clinical

    Research recommendation
    Published
    18 October 2018

  7. Second-line maintenance therapy in children and young people (under 16):- Is maintenance therapy more effective with a paediatric low dose of ICS plus a leukotriene receptor antagonist (LTRA) or with a paediatric low dose of ICS plus a long-acting beta2 agonist (LABA) in the treatment of asthma in children and young people (under 16) who have uncontrolled asthma on a paediatric low dose of ICS alone?

    beta2 agonist (LABA) in the treatment of asthma in children and young people (under 16) who have uncontrolled asthma on a...

    Research recommendation
    Published
    18 October 2018

  8. Decreasing pharmacological treatment:- In adults, young people and children with well-controlled asthma, what are the objective measurements and prognostic factors that indicate that a decrease in regular maintenance treatment is appropriate?

    pharmacological treatment:- In adults, young people and children with well-controlled asthma, what are the objective measurements and...

    Research recommendation
    Published
    18 October 2018

  9. Mortality: respiratory (IND281)

    This indicator covers under 75 mortality from respiratory disease. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

    Network / system level indicators
    Published
    30 September 2023

  10. Sustainability

    NICE is committed to supporting the national agenda for achieving a sustainable health and care system.

  11. Smoking: smoking status for people with long-term conditions (IND97)

    This indicator covers the percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses whose notes record smoking status in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM38

    General practice indicators suitable for use in QOF
    Published
    1 August 2011

  12. Digital platforms recommended to help people manage their asthma

    People with asthma could benefit from digital tools on their phones or tablets to help them better manage their condition, states our draft guidance published today.

    News
    Last updated
    7 January 2026

  13. The asthma guideline – one year on

    Home News Podcasts The asthma guideline – one year on Podcasts 29 January 2026 Listen About this episode Developed collaboratively by the

    News
    Last updated
    30 January 2026

  14. Past appeals and decisions

    Past technology appraisal appeals and decisions

  15. Lurbinectedin with atezolizumab for maintenance treatment of extensive-stage small-cell lung cancer [ID6526]

    In development Reference number: GID-TA11502 Expected publication date:  02 December 2026

    Technology appraisal guidance
    In development